Stay updated on Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.

Latest updates to the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page’s UI revision/version marker has been updated from v3.5.2 to v3.5.3, indicating a change to the ClinicalTrials.gov interface release rather than study record information.SummaryDifference0.0%

- Check13 days agoChange DetectedA new version entry on 2026-04-13 adds Contacts/Locations and Study Status and updates the revision to v3.5.2, replacing the prior v3.5.0.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedAdds Contacts/Locations and Study Status to the latest record version (around 2026-03-18/19) and removes a prior entry dated 2026-01-16.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.5.0 was added as the latest version and Revision: v3.4.3 was removed from the history.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision: v3.4.2 is now displayed; the notice about a lapse in government funding and the earlier Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Apalutamide Study in High-Risk Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apalutamide Study in High-Risk Prostate Cancer Clinical Trial page.